No registrations found.
ID
Source
Brief title
Health condition
Obsessive Compulsive Disorder
Exposure in vivo with response prevention
Behaviour therapy
Treatment experience
Cognitive therapy
Antidepressants
SSRI's
Fluvoxamine
Algorithm
Obssieve Compulsieve stoornis
Exposure in vivo met repons preventie
Gedragstherapie
Cognitieve therapie
Therapie ervaring
Antidepressiva
SSRI's
Fluvoxamine
Behandelalgoritme
Sponsors and support
Intervention
Outcome measures
Primary outcome
Yale-Brown Obsessive Compulsive Scale (Y-BOCS), measured by trained and weekly supervised interviewers who are blind to the treatment condition of the patients.
Secondary outcome
1. Padua Inventory-Revised (PI-R)
2. Anxiety Discomfort Scale (ADS)
3. Beck Depression Inventory (BDI)
Background summary
Phase 1:
Background:
The importance of the therapist’s education and experience for the successful behavior treatment of OCD has not been investigated. Data on the relative effectiveness of self-controlled versus therapist-controlled exposure in vivo with response prevention (ERP) have yielded conflicting results. The present study evaluated the effectiveness of different formats of ERP in a referred sample of Obsessive Compulsive Disorder (OCD) patients.
Method:
Of the 146 eligible outpatients with primary DSM-IV-defined OCD, 118 patients enrolled in this randomized controlled trial and were randomly assigned to 1) therapist-controlled ERP performed by experienced behavior therapists; 2) therapist-controlled ERP performed by master students of clinical psychology; 3) self-controlled ERP performed by experienced behavior therapists; and 4) self-controlled ERP performed by master students of clinical psychology. This trial was performed from January 1999 to January 2005.
Results:
The results clearly reveal that ERP can be effectively delivered in different ways. On the one hand patient-controlled ERP is as effective as therapist-controlled ERP and on the other hand ERP delivered by experienced behavior therapists is equally effective as ERP delivered by master student therapists in the treatment of OCD. There was no significant difference in clinical outcome between these different form of ERP at posttreatment.
Conclusions:
Our results suggest that master student-therapists may become effective in the deliverance of ERP with OCD patients . Our results suggest that less-experienced and no certified behavior therapist were as capable as the behavior therapists with long experience and specialty certification in treating OCD patients. However, all therapists were instructed to deliver a standardized treatment, and all were adequately trained and supervised. Furthermore, therapist-controlled ERP was not more effective than self-controlled ERP in patients with OCD.
Study objective
1. Phase I:
Exposure in vivo with response prevention (ERP) performed by experienced behavior therapists is more effective than ERP performed by master clinical psychology students. Therapist-controlled ERP is more effective than self-controlled ERP. ERP performed by experienced behavior therapists leads to a lower drop-out rate than ERP performed by master clinical psychology students.
2. Phase II:
After 12-week treatment with exposure in vivo with response prevention, in non-responders, 12-week treatment with cognitive therapy is superior to 12-week treatment with fluvoxamine in patients with Obsessive Compulsive Disorder.
Study design
First Phase:
Pretest and posttest after 12-weeks. In case of non-response (defined as improvement of less than 35% measured with the Y-BOCS) admittance to phase 2
Second Phase:
Pretest and posttest after 12 weeks
Follow-up measures after 3 and 12 months
Intervention
First Phase:
12-week exposure in vivo with response prevention (ERP). Participants were randomized to:
1. Therapist-controlled ERP performed by experienced behavior therapists;
2. Therapist-controlled ERP performed by clinical psychology students;
3. Self-controlled ERP performed by experienced behavior therapists;
4. Self-controlled ERP performed by clinical psychology students
Second Phase:
Non-responders of the first phase were randomised to 12 weeks treatment with:
1. Cognitive therapy;
2. Fluvoxamine.
Department of Psychiatry / GGZ Buitenamstel <br>
A.J.L.M. Balkom, van
A.J. Ernststraat 887
Amsterdam 1081 HL
The Netherlands
+31 (0)20 7884549
vanbalkom@ggzba.nl
Department of Psychiatry / GGZ Buitenamstel <br>
A.J.L.M. Balkom, van
A.J. Ernststraat 887
Amsterdam 1081 HL
The Netherlands
+31 (0)20 7884549
vanbalkom@ggzba.nl
Inclusion criteria
1. Main diagnosis of Obsessive Compulsive Disorder according to DSM-IV
2. Duration at least one year
3. Age > 16 years
4. Informed Consent
5. No treatment for OCD elsewhere
6. Willing and able to stop with antidepressant and/or antipsychotic treatment.
Exclusion criteria
1. Obsessions only
2. Suicidal intention
3. Organic brain disease
4. Past or present psychotic disorder
5. Psychoactive substance use disorder
6. Borderline or anti-social personality disorder
7. Pregnancy
8. CBT 6 months before inclusion
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL1384 |
NTR-old | NTR1444 |
Other | VU University Medical Center : 97/211A |
ISRCTN | ISRCTN wordt niet meer aangevraagd |